Pramlintide, an amylin analog, selectively delays gastric emptying: Potential role of vagal inhibition

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 278, Issue 6 41-6, 2000, Pages

  Samsom, Melvin ^a   Szarka, Lawrence A ^a   Camilleri, Michael ^a   Vella, Adrian ^a   Zinsmeister, Alan R ^a   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Colonic transit; Diabetes mellitus; Glucose; Pancreatic polypeptide

Indexed keywords

AMYLIN DERIVATIVE; GLUCOSE; PANCREAS POLYPEPTIDE; PRAMLINTIDE; PROTEIN;

ADULT; ARTICLE; CLINICAL TRIAL; COLON MOTILITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GASTROINTESTINAL MOTILITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; VAGUS NERVE;

EID: 0033949323     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2000.278.6.g946     Document Type: Article

References (29)

1. Beaumont K, Kenney MA, Young AA, and Rink TJ. High affinity amylin binding sites in rat brain. Mol Pharmacol 44: 493-497, 1993.
2. Burton DD, Camilleri M, Mullan BP, Forstrom LA, and Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med 38: 1807-1810, 1997.
3. Camilleri M, Balm RK, and Low PA. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clin Auton Res 3: 95-100, 1993.
4. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman NJ, and Zinsmeister AR. Human gastric emptying and colonie filling of solids characterized by a new method. Am J Physiol Gastrointest Liver Physiol 257: G284-G290, 1989.
5. Camilleri M, Malagelada J-R, Brown ML, Becker G, and Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol Gastrointest Liver Physiol 249: G580-G585, 1985.
6. Camilleri M and Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonie motility disorders. Gastroenterology 103: 36-42, 1992.
7. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, and Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 36: 609-615, 1991.
8. Elashoff JD, Reedy TJ, and Meyer JH. Analysis of gastric emptying data. Gastroenterology 83: 1306-1312, 1982.
9. Fineman M, Giotta M, and Thompson RG. Amylin response following Sustacal ingestion is diminished in Type II diabetic patients treated with insulin (Abstract). Diabetologia 39: A149, 1996.
10. Gedulin BR, Rink TJ, and Young AA. Dose-response for glucagon static effect of amylin in rats. Metabolism 46: 67-70, 1997.
11. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, and Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 100: 1311-1318, 1991.
12. Jodka C, Green D, Young A, and Gedulin B. Amylin modulation of gastric emptying in rats depends upon an intact vagus nerve (Abstract). Diabetes 45: 235A, 1996.
13. Koch MB, Go VL, and DiMagno EP. Can plasma pancreatic polypeptide be used to detect diseases of the exocrine pancreas? Mayo Clin Proc 60: 259-265, 1985.
14. Koda JE, Fineman M, Rink TJ, Dailey GE, Muchmore DB, and Linarelli LG. Amylin concentrations and glucose control. Lancet 339: 1179-1180, 1992.
15. Kolterman OG, Gottlieb A, Moyses C, and Colburn W. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18: 1179-1182, 1995.
16. Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, Moyses C, and Tattersall RB. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia 40: 82-88, 1997.
17. Kong MF, Stubbs TA, King P, Macdonald IA, Lambourne JE, Blackshaw PE, Perkins AC, and Tattersall RB. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabetologia 41: 577-583, 1998.
18. Proano M, Camilleri M, Phillips SF, Brown ML, and Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol Gastrointest Liver Physiol 258: G856-G862, 1990.
19. Rink TJ, Beaumont K, Koda J, and Yong A. Structure and biology of amylin. Trends Pharmacol Sci 14: 113-118, 1993.
20. Schirra J, Leicht P, Hildebrand P, Beglinger C, Arnold R, Goke B, and Katschinski M. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus. J Endocrinol 156: 177-186, 1998.
21. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, and Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62: 553-567, 1994.
22. Silvestre RA, Rodriguez-Gallardo J, Gutierrez E, and Marco J. Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas. Regul Pept 68: 31-35, 1997.
23. Talley NJ, Phillips SF, Melton LJ III, Wiltgen C, and Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 111: 671-674, 1989.
24. Thompson RG, Pearson L, and Kolterman OG. Effects of 4 weeks'administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations. Diabetologia 40: 1278-1285, 1997.
25. Thompson RG, Pearson L, Schoenfeld SL, and Kolterman OG. Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type II diabetes using insulin. Diabetes Care 21: 987-993, 1998.
26. Young A, Gedulin B, Jodka C, and Green D. Insulin-induced hypoglycemia reverses amylin inhibition of gastric emptying in rats (Abstract). Diabetes 45: 187A, 1996.
27. Young AA, Gedulin BR, and Rink TJ. Dose-response for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metabolism 45: 1-3, 1996.
28. Young AA, Gedulin BR, Vine W, Percy A, and Rink TJ. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injection of amylin. Diabetologia 38: 642-648, 1995.
29. Young A, Pittner R, Gedulin B, Vine W, and Rink T. Amylin regulation of carbohydrate metabolism. Biochem Soc Trans 23: 325-331, 1995.